Clinical Trails With the end of the Brexit transition period on 31 December 2020, the known conditions will change and pharmaceutical companies not prepared will face serious issues and uncertainties. No extension of the transition period has been requested, and according to a joint technical notice by the European Commission, EMA and HMA, no further prolongation beyond 2020 is possible. EU pharmaceutical law will no longer apply for the UK.
Brexit: the how of EU clinical trials post 2020
Sponsored PublicationsClinical Trails With the end of the Brexit transition period on 31 December 2020, the known conditions will change and pharmaceutical companies not prepared will face serious issues and uncertainties. No extension of the transition period has been requested, and according to a joint technical notice by the European Commission, EMA and HMA, no further prolongation beyond 2020 is possible. EU pharmaceutical law will no longer apply for the UK.
Vifor Pharma in US$100m licence deal with Cara Therapeutics
Latest NewsVifor Pharma and Cara Therapeutics have signed a US license agreement for Korsuva to treat dialysis patients with pruritus.
Radiant Precision
Sponsored PublicationsPrecision Oncology High-Precision Radionuclide Therapy is a promising, new generation of targeted molecular therapy in which the smallest amounts of medical radioactivity find their way through the bloodstream specifically to the tumour cells for diagnosis and treatment of cancer.
cellQART® Cell Culture Inserts
Sponsored PublicationsHigh-quality cell culture inserts of the new brand cellQART® can now also be purchased directly from the German manufacturer SABEU.
Atriva Therapeutics gets €24m from EIB
Latest NewsAtriva Therapeutics has secured a €24m loan to push the development of its COVID-19 programme ATR-002, an antiviral, anti-inflammatory MEK inhibitor.
Topas raises €22m in Series B financining
Latest NewsTopas Therapeutics GmbH will use the €22m proceeds from a Series B Financing to advance two pipeline candidates.
AMR – the silent pandemic that can still be contained
OpinionThe COVID-19 pandemic is having a devastating effect on global health and an unprecedented impact on the economy. As the world struggles with the challenges brought on by this pandemic, the threat of the next one is already looming in the form of AMR.
Valneva is looking for a new CFO
AppointmentsDavid Lawrence, Chief Financial Officer of French Valneva, will retire at the end of 2020.
Siemens launches COVID-19 antigen lateral flow test
Latest NewsSiemens Healthineers has launched its Clinitest Rapid COVID-19 Antigen Test in Europe, which can identify persons infected with SARS-CoV-2 in 15 minutes.
Priothera closes €30m Series A financing
Latest NewsPriothera Ltd. wants to use €30m from a Series A financing to develop a licenced therapy for acute myeloid leukemia (AML).